<PAGE> 1
-------------------------
OMB APPROVAL
-------------------------
OMB NUMBER: 3235-0145
Expires:December 31, 1997
Estimated average burden
hours per response..14.90
-------------------------
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13d-102)
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 1 )*
BRITISH BIOTECH PLC
(Name of Issuer)
Common Stock, par value (pound)0.05 per share
(Title of Class of Securities)
110515103
(CUSIP Number)
Check the following box if a fee is being paid with this statement / / . (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 13 pages
<PAGE> 2
- ------------------------------- ---------------------------------
CUSIP NO. 110515103 13G PAGE 2 OF 8 PAGES
- ------------------------------- ---------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
B.A.T Industries p.l.c.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
England
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
-0-
NUMBER OF
SHARES -------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 2,638,880
REPORTING
PERSON -------------------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
-0-
-------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,638,880
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,638,880
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
N.A.
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.4%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
HC
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 2 of 13 pages
<PAGE> 3
Items 4 and 5 of the Statement on Schedule 13G, dated February 5, 1997,
filed by B.A.T Industries p.l.c. and Farmers Group, Inc., is hereby amended and
restated to read in their entirety as follows:
Item 4 Ownership
(a) Amount Beneficially Owned
2,638,880
(b) Percent of Class:
0.4%
(c) Number of shares as to which person has:
(i) Sole voting power: -0-
(ii) Shared voting power: 2,638,880
(iii) Sole disposition power: -0-
(iv) Shared disposition power: 2,638,880
Item 5 Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of
the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of
securities, check the following box. /X/ .
Page 3 of 13 pages
<PAGE> 4
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
B.A.T INDUSTRIES p.l.c.
Dated February 25, 1997 By: /s/ Anthony Robert Holliman
---------------------------------------
Name: Anthony Robert Holliman
Title: Assistant Corporate Secretary
Page 4 of 13 pages
<PAGE> 5
Exhibit Index
<TABLE>
<CAPTION>
Exhibit Description Page Number
- ------- ----------- -----------
<S> <C> <C>
I Schedule 13G, dated February 5, 1997 6
</TABLE>
Page 5 of 13 pages
<PAGE> 1
-------------------------
OMB APPROVAL
-------------------------
OMB NUMBER: 3235-0145
Expires:December 31, 1997
Estimated average burden
hours per response..14.90
-------------------------
Exhibit I
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13d-102)
INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
BRITISH BIOTECH PLC
(Name of Issuer)
Common Stock, par value (pound)0.05
(Title of Class of Securities) per share
110515103
(CUSIP Number)
Check the following box if a fee is being paid with this statement /X/ . (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7).
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 6 of 13 pages
<PAGE> 2
- ------------------------------- ---------------------------------
CUSIP NO. 110515103 13G PAGE 2 OF 8 PAGES
- ------------------------------- ---------------------------------
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
B.A.T Industries p.l.c.
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) / /
(b) / /
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
England
- --------------------------------------------------------------------------------
5 SOLE VOTING POWER
-0-
NUMBER OF
SHARES --------------------------------------------------------------
BENEFICIALLY 6 SHARED VOTING POWER
OWNED BY
EACH 2,638,880
REPORTING
PERSON --------------------------------------------------------------
WITH 7 SOLE DISPOSITIVE POWER
-0-
--------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
2,638,880
- --------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
2,638,880
- --------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* / /
N.A.
- --------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
7.30%
- --------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
HC
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
Page 7 of 13 pages
<PAGE> 3
Item 1 (a). Name of Issuer:
BRITISH BIOTECH PLC
Item 1 (b). Address of Issuer's Principal Executive Office:
Watlington Road
Dowley
Oxford OX4 5LY
England
Item 2(a). Name of Person Filing:
B.A.T Industries p.l.c., an English corporation ("B.A.T").
Item 2(b). Address of Principal Business Office or, if none, Residence:
B.A.T Industries p.l.c.
Windsor House
50 Victoria Street
London SW1H ONL
England
Item 2(c). Citizenship:
B.A.T Industries p.l.c. - England
Item 2(d). Title of Class of Securities:
Common stock, par value (pound)0.05 per share
Item 2(e). CUSIP Number:
110515103
Item 3. This statement is filed pursuant to Rule 13d-1(b) by
B.A.T, a Parent Holding Company, in accordance with Rule
13d-1(b)(ii)(G).
Page 8 of 13 pages
<PAGE> 4
Item 4. Ownership:
(a) Amount Beneficially Owned:
2,638,880
The shares being reported were acquired by various
investment funds for which subsidiaries of B.A.T
act as manager and investment adviser and exercise
investment discretion. No such subsidiary
beneficially owns in excess of 5% of the class of
shares for which this report is being made. The
filing of this statement by B.A.T shall not be
construed as an admission that B.A.T is, for the
purposes of Section 13(d) or 13(g) of the Act or
under the laws or regulations of the United
Kingdom, the beneficial owner of any securities
covered by this statement.
(b) Percent of Class:
7.30%
(c) Number of shares as to which person has:
(i) Sole voting power: -0-
(ii) Shared voting power: 2,638,880
(iii) Sole disposition power: -0-
(iv) Shared disposition power: 2,638,880
Item 5. Ownership of Five Percent or Less of a Class:
Not Applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another
Person:
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on by the Parent Holding
Company:
See Exhibit I.
Item 8. Identification and Classification of Members of the Group:
Not Applicable.
Page 9 of 13 pages
<PAGE> 5
Item 9. Notice of Dissolution of the Group:
Not Applicable.
Item 10. Certification:
By signing below I certify that, to the best of my
knowledge and belief, the securities referred to above
were acquired in the ordinary course of business and
were not acquired for the purpose of and do not have the
effect of changing or influencing the control of the
issuer of such securities and were not acquired in
connection with or as a participant in any transaction
having such purpose or effect.
Page 10 of 13 pages
<PAGE> 6
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief,
I certify that the information set forth in this statement is true, complete and
correct.
B.A.T INDUSTRIES p.l.c.
Dated February 5, 1997 By: /s/ Anthony Robert Holliman
-----------------------------
Name: Anthony Robert Holliman
Title: Assistant Corporate Secretary
Page 11 of 13 pages
<PAGE> 7
Exhibit Index
<TABLE>
<CAPTION>
Exhibit Description Page Number
- ------- ----------- -----------
<S> <C> <C>
I Identification and Classification of Subsidiaries 13
</TABLE>
Page 12 of 13 pages
<PAGE> 8
Exhibit I
The shares of BRITISH BIOTECHN PLC which are the Subject of this Schedule
13G were acquired by various investment funds for which subsidiaries of B.A.T.
act as manager and investment adviser and exercise investment discretion. The
identity of such subsidiaries is as follows:
Eagle Star Life Assurance Company Limited
60 St. Mary Axe
London EC3A 8JQ
England
Eagle Star Insurance Company Limited
60 St. Mary Axe
London EC3A 8JQ
England
Eagle Star Reinsurance Company Limited
60 St. Mary Axe
London EC3A 8JQ
England
Each of the foregoing subsidiaries is an insurance company for
purposes of Item 3 of this Statement.
Page 13 of 13 pages
